This is an automated archive made by the Lemmit Bot.

The original was posted on /r/upliftingnews by /u/ArgentineBeauty on 2026-08-01 21:25:32+00:00.

Original Title: The FDA has approved Lipfendra, the first once daily oral PCSK9 inhibitor, after trials showed it lowered LDL cholesterol by 56% to 59% in adults with high cholesterol, giving patients a needle free alternative to injectable cholesterol drugs.